150 filings
10-K
2023 FY
CERE
Cerevel Therapeutics Holdings Inc
Annual report
27 Feb 24
4:02pm
8-K
CERE
Cerevel Therapeutics Holdings Inc
16 Feb 24
Submission of Matters to a Vote of Security Holders
4:46pm
DEFA14A
CERE
Cerevel Therapeutics Holdings Inc
9 Feb 24
Additional proxy soliciting materials
9:00am
DEFM14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Proxy related to merger
7:44am
PRER14A
CERE
Cerevel Therapeutics Holdings Inc
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
5otze
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
pby jrzlnq
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
gtaj ws9xunb7gbi
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
aftghm
1 Nov 23
Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
6:39am
8-K
qbd5uo2 uwc
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
424B5
adpmso3 29t
12 Oct 23
Prospectus supplement for primary offering
4:16pm
8-K
btwlmtfdne2j60q9
11 Oct 23
Results of Operations and Financial Condition
4:14pm
424B5
04nm5ox3vwr02v2
11 Oct 23
Prospectus supplement for primary offering
4:08pm
8-K
63cir
2 Aug 23
Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
6:43am
8-K
z7rbx
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
li0fr90
10 May 23
Cerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
6:54am